Skip to the page

Data / Drug companies / NuCare Pharmaceuticals, Inc.

NuCare Pharmaceuticals, Inc.: 70 products in the FDA NDC directory, labeler code 66267

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

NuCare Pharmaceuticals, Inc. (labeler code 66267) lists 70 products in the FDA National Drug Code Directory, covering 50 finished drugs by generic name. By type: 64 prescription drugs, 6 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on November 15, 2017.

The request: Watch NuCare Pharmaceuticals, Inc. (FDA labeler code 66267): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
66267
Products in commercial distribution
70
Packages
171
Finished drugs by generic name
50
Prescription products
64
Over the counter products
6
Controlled substance products
Schedule II 1, Schedule III 1, Schedule IV 1
Started marketing in the last 12 months
0
Products with a marketing end date set
1
Earliest marketing start
December 14, 1981
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Generic drugs (ANDA)6694.3%
Over the counter monograph drugs45.7%

Products by type

TypeProductsShare
Prescription drugs6491.4%
Over the counter drugs68.6%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Tablet3550%
Capsule1014.3%
Cream68.6%
Tablet, film coated45.7%
Powder, for suspension34.3%
Ointment22.9%
Tablet, chewable22.9%
Solution22.9%
Tablet, delayed release22.9%
Tablet, film coated, extended release11.4%
Tablet, extended release11.4%
Capsule, liquid filled11.4%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Oxybutynin Chloride66267-642TabletGeneric drugs (ANDA)November 15, 2017
Gemfibrozil66267-436TabletGeneric drugs (ANDA)July 8, 2016
Naproxen66267-373Tablet, delayed releaseGeneric drugs (ANDA)July 5, 2016
Allopurinol66267-665TabletGeneric drugs (ANDA)April 29, 2015
Doxazosin66267-377TabletGeneric drugs (ANDA)April 22, 2015
Polycin66267-925OintmentGeneric drugs (ANDA)November 12, 2014
Acyclovir66267-399TabletGeneric drugs (ANDA)September 10, 2014
Hydrochlorothiazide66267-106TabletGeneric drugs (ANDA)April 10, 2013
Methocarbamol66267-803TabletGeneric drugs (ANDA)March 20, 2013
Methocarbamol66267-146TabletGeneric drugs (ANDA)March 20, 2013
Hydrocodone Bitartrate and Acetaminophen66267-319TabletGeneric drugs (ANDA)April 11, 2012
Indomethacin66267-120CapsuleGeneric drugs (ANDA)November 1, 2011
Indomethacin66267-119CapsuleGeneric drugs (ANDA)November 1, 2011
Glyburide66267-103TabletGeneric drugs (ANDA)October 5, 2010
Phendimetrazine Tartrate66267-394TabletGeneric drugs (ANDA)September 15, 2010
Propranolol Hydrochloride66267-261TabletGeneric drugs (ANDA)June 21, 2010
Sulfamethoxazole and Trimethoprim66267-816TabletGeneric drugs (ANDA)February 16, 2010
Sulfamethoxazole and Trimethoprim66267-196TabletGeneric drugs (ANDA)February 16, 2010
Diphenhydramine HCL66267-779CapsuleOver the counter monograph drugsJanuary 27, 2010
Diphenhydramine HCL66267-081CapsuleOver the counter monograph drugsJanuary 27, 2010
Clonidine hydrochloride66267-464TabletGeneric drugs (ANDA)September 21, 2009
Verapamil hydrochloride66267-212Tablet, film coated, extended releaseGeneric drugs (ANDA)September 17, 2009
Nifedipine66267-831CapsuleGeneric drugs (ANDA)August 11, 2009
Folic Acid66267-217TabletGeneric drugs (ANDA)January 12, 2009
Ibu66267-964TabletGeneric drugs (ANDA)November 20, 2008

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.